19.03
price down icon0.78%   -0.15
after-market Handel nachbörslich: 19.03
loading
Schlusskurs vom Vortag:
$19.18
Offen:
$19.26
24-Stunden-Volumen:
33,396
Relative Volume:
0.47
Marktkapitalisierung:
$931.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.28M
KGV:
-9.5355
EPS:
-1.9957
Netto-Cashflow:
$-57.45M
1W Leistung:
-2.96%
1M Leistung:
-2.81%
6M Leistung:
+55.22%
1J Leistung:
+57.93%
1-Tages-Spanne:
Value
$18.67
$19.98
1-Wochen-Bereich:
Value
$18.67
$20.00
52-Wochen-Spanne:
Value
$10.55
$23.08

Oculis Holding Ag Stock (OCS) Company Profile

Name
Firmenname
Oculis Holding Ag
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
OCS's Discussions on Twitter

Vergleichen Sie OCS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OCS
Oculis Holding Ag
19.03 931.20M 0 -75.28M -57.45M -1.9957
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Oculis Holding Ag Stock (OCS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-05 Eingeleitet Chardan Capital Markets Buy
2023-10-05 Eingeleitet Stifel Buy
2023-06-14 Eingeleitet BofA Securities Buy
2023-06-12 Eingeleitet H.C. Wainwright Buy
2023-06-08 Eingeleitet Robert W. Baird Outperform
2023-05-10 Eingeleitet Pareto Buy
2023-04-28 Eingeleitet Wedbush Outperform
Alle ansehen

Oculis Holding Ag Aktie (OCS) Neueste Nachrichten

pulisher
02:18 AM

Oculis Holding AG (NASDAQ:OCS) Short Interest Update - Defense World

02:18 AM
pulisher
Mar 21, 2025

Oculis Holding AG (NASDAQ:OCS) Short Interest Down 14.1% in February - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities - MarketScreener

Mar 20, 2025
pulisher
Mar 19, 2025

Insider Buying: Oculis Holding Independent Director Bought CHF326k Of Shares - simplywall.st

Mar 19, 2025
pulisher
Mar 19, 2025

Lionel Carnot Spends CHF326k On Oculis Holding Stock - Yahoo Canada Finance

Mar 19, 2025
pulisher
Mar 17, 2025

HC Wainwright Comments on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

Robert W. Baird Boosts Oculis (NASDAQ:OCS) Price Target to $41.00 - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

HC Wainwright Lowers Oculis (NASDAQ:OCS) Price Target to $29.00 - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

Oculis (NASDAQ:OCS) Sees Strong Trading Volume After Analyst Upgrade - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update - Informazione.it

Mar 15, 2025
pulisher
Mar 14, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

(OCS) Investment Analysis - Stock Traders Daily

Mar 14, 2025
pulisher
Mar 13, 2025

Oculis Holding AG (OCS) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

Stifel maintains Buy on Oculis shares, price target at $35 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Oculis price target raised to $32 from $31 at BofA - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Oculis (NASDAQ:OCS) Shares Gap Down Following Weak Earnings - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Oculis Holding AG Reports 2024 Financial Results - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Oculis Reports 2024 Fourth Quarter Net Loss, Completes $100 Million Equity Financing to Support Pipeline - Vision Monday

Mar 13, 2025
pulisher
Mar 12, 2025

Stifel maintains Buy on Oculis shares, price target at $35 - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Oculis Holding AG reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2025
pulisher
Mar 11, 2025

Oculis Holding AG Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Oculis (OCS) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

(OCSAW) On The My Stocks Page - news.stocktradersdaily.com

Mar 06, 2025
pulisher
Mar 05, 2025

Oculis to Present at Upcoming March Investor Conference - The Manila Times

Mar 05, 2025
pulisher
Mar 03, 2025

(OCS) Investment Report - Stock Traders Daily

Mar 03, 2025
pulisher
Feb 21, 2025

(OCS) On The My Stocks Page - Stock Traders Daily

Feb 21, 2025
pulisher
Feb 16, 2025

Oculis Holding AG (NASDAQ:OCS) Short Interest Down 68.6% in January - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

Oculis (NASDAQ:OCS) Shares Down 7.2%Should You Sell? - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Oculis Holding AG Prices $100 Million Oversubscribed Share Offering - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

Oculis Holding Prices Offering of 5 Million Shares -February 14, 2025 at 04:36 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

Biopharmaceutical Company Oculis Seeks $100 Million from Share Sale -February 14, 2025 at 12:56 am EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 13, 2025

Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares - The Manila Times

Feb 13, 2025
pulisher
Feb 13, 2025

Major Funding Breakthrough: Oculis Secures $100M for Revolutionary Eye Treatment Development - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Oculis Raises Massive $100M War Chest: Major Pipeline Expansion for Revolutionary Eye Treatment - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Oculis greinir frá umframeftirspurn og öðrum niðurstöðum 100 milljón USD útboðs á almennum hlutum - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 12, 2025

Institutions along with retail investors who hold considerable shares inOculis Holding AG (NASDAQ:OCS) come under pressure; lose 8.9% of holdings value - Simply Wall St

Feb 12, 2025
pulisher
Feb 10, 2025

(OCS) Trading Report - Stock Traders Daily

Feb 10, 2025
pulisher
Feb 10, 2025

abrdn plc Buys 188,871 Shares of Oculis Holding AG (NASDAQ:OCS) - MarketBeat

Feb 10, 2025
pulisher
Feb 07, 2025

Oculis (NASDAQ:OCS) Trading Down 0.2%Time to Sell? - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

Insider Alert: Oculis Leadership Team Hits Major Share Vesting Milestone - StockTitan

Feb 07, 2025

Finanzdaten der Oculis Holding Ag-Aktie (OCS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):